Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 57 Breast Neoplasms 35 Neoplasms 32 Parkinson Disease 4, Autosomal Dominant Lewy Body 25 Multiple Myeloma 24 Leukemia, Myeloid, Acute 20 Recurrence 18 Neoplasm Metastasis 17 Colorectal Neoplasms 17 Ovarian Neoplasms 15 Lymphoma, Non-Hodgkin 15 Melanoma 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Carcinoma, Renal Cell 14 Leukemia 13 Lymphoma, Follicular 12 Urinary Bladder Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 11 Lung Neoplasms 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Hematologic Neoplasms 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Prostatic Neoplasms 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma 9 Adenocarcinoma 9 Thyroid Neoplasms 8

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has announcements × Advanced Cancer × Clear all

NCT02743494 2025-11-18

CheckMate 577

Bristol-Myers Squibb

Phase 3 Completed

794 enrolled 13 charts 1 FDA

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡